Clinical Trial Update: the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy and safety of Ginsenoside Rg3 Capsule in preventing postoperative recurrence of hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Ginsenoside Rg3 Capsule (ginsenoside Rg3)

Snippet

Sponsor: ShenFeng | Conditions: Stage I Hepatocellular Carcinoma, Stage II Hepatocellular Carcinoma | NA | Status: COMPLETED